These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 19485996

  • 21. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H.
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [Abstract] [Full Text] [Related]

  • 22. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y, Nishie W, Izumi K, Shimizu H.
    Front Immunol; 2019 Apr; 10():1224. PubMed ID: 31191560
    [Abstract] [Full Text] [Related]

  • 23. Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins.
    Hayakawa T, Teye K, Hachiya T, Uehara R, Hashiguchi M, Kawakami T, Li X, Tsuchisaka A, Ohara K, Sogame R, Koga H, Hamada T, Ohata C, Furumura M, Ishii N, Fukano H, Shimozato K, Hashimoto T.
    Eur J Dermatol; 2016 Apr 01; 26(2):155-63. PubMed ID: 27087683
    [Abstract] [Full Text] [Related]

  • 24. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF.
    Br J Dermatol; 2009 Feb 01; 160(2):429-32. PubMed ID: 18808416
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients.
    Ingen-Housz-Oro S, Plée J, Belmondo T, Maizières M, Pham BN, Hüe S, Ortonne N, Durlach A, Wolkenstein P, Chosidow O, Bernard P.
    Dermatology; 2015 Feb 01; 231(1):50-5. PubMed ID: 25871736
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF, Cozzani E, Delaporte E, Nicolas JF, Parodi A, Claudy A.
    J Clin Immunol; 1998 May 01; 18(3):202-9. PubMed ID: 9624579
    [Abstract] [Full Text] [Related]

  • 31. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS.
    Arch Dermatol; 2011 Mar 01; 147(3):291-2. PubMed ID: 21422335
    [No Abstract] [Full Text] [Related]

  • 32. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.
    Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M.
    J Invest Dermatol; 2011 Nov 01; 131(11):2271-80. PubMed ID: 21697892
    [Abstract] [Full Text] [Related]

  • 33. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R, Martinache S, Engstner M, Enk AH, Hadaschik EN.
    Dermatol Ther; 2016 Nov 01; 29(6):419-423. PubMed ID: 27550573
    [Abstract] [Full Text] [Related]

  • 34. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S, Yuan H, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR, Hammers CM.
    Br J Dermatol; 2019 May 01; 180(5):1099-1106. PubMed ID: 30315657
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M, Lehman JS, Camilleri MJ, Drage LA, Wieland CN.
    J Am Acad Dermatol; 2019 Aug 01; 81(2):472-479. PubMed ID: 30928465
    [Abstract] [Full Text] [Related]

  • 37. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R, Schmidt E, Chimanovitch I, Leverkus M, Bröcker EB, Zillikens D.
    J Am Acad Dermatol; 2000 Apr 01; 42(4):577-83. PubMed ID: 10727301
    [Abstract] [Full Text] [Related]

  • 38. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid.
    Mersmann M, Dworschak J, Ebermann K, Komorowski L, Schlumberger W, Stöcker W, Zillikens D, Probst C, Schmidt E.
    Arch Dermatol Res; 2016 Jan 01; 308(1):31-8. PubMed ID: 26498290
    [Abstract] [Full Text] [Related]

  • 39. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC, Wang B, Yuan H, Zheng J, Pan M.
    J Dermatol; 2020 Apr 01; 47(4):317-326. PubMed ID: 32048350
    [Abstract] [Full Text] [Related]

  • 40. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E, members of the BLISTER Study Group.
    Br J Dermatol; 2018 Oct 01; 179(4):918-924. PubMed ID: 29607480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.